Frazier Life Sciences Acquisition Corp. II — Form 8-K
Filed October 15, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 22/100
What the filing says
Frazier Life Sciences Acquisition Corp. II (a blank-check company) issued 7,500,000 Class A ordinary shares at $10.00/share on October 15, 2026, raising $75M gross proceeds via Jefferies LLC as underwriter. Sponsor Frazier Life Sciences Holdings II LLC purchased 300,000 private placement shares at $10.00/share ($3M). Trust account funded with net IPO proceeds plus private placement proceeds to equal $82.5M (7.5M public shares + 0.3M PIPE × $10). Deferred underwriting discount of $0.40/share ($3M) payable upon business combination close. Company also received forward purchase commitment from Frazier Life Sciences Public Fund, L.P. for 2.5M shares at $10.00/share ($25M) at business combination close.
Why this rating
Routine SPAC IPO filing. No company operations pre-combination; proceeds in trust. Size ~$75M unknown relative to any target. Standard SPAC structure.
See more from October 15, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.